Tylosin Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the tylosin market grown over the years?
The tylosin market has experienced considerable growth over the past few years. It is projected to expand from $0.74 billion in 2024, to $0.79 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.0%. The surge in the historic period can be credited to factors such as the hike in livestock production, the use of antibiotic growth promoters (AGPS), enhanced awareness regarding veterinary health, governmental regulations and approvals, as well as a rising occurrence of livestock ailments.
What Is the forecasted market size and growth rate for the tylosin market?
In the forthcoming years, the tylosin market is projected to witness robust growth, reaching $0.98 billion in 2029 with a 5.7% compound annual growth rate (CAGR). This expected growth during the projection period can be linked to factors such as the globally increasing meat consumption, an emphasis on animal health and well-being, the proliferation of livestock farming in developing markets, changes in regulations and the prohibition on antibiotic growth promoters, and the escalating demand for organic and antibiotic-free meat. The forecasted period will likely see trends like a growing preference for alternatives to antibiotics, stricter regulatory guidelines, advancements in precision livestock farming, expansion in the organic and antibiotic-free meat market, and development of veterinary services and infrastructure.
Get your tylosin market report here!
https://www.thebusinessresearchcompany.com/report/tylosin-global-market-report
What are the major factors driving growth in the tylosin market?
The anticipated rise in meat production is predicted to stimulate the advancement of the tylosin market. Meat production pertains to breeding, slaughtering, and processing animals for human consumption. This growth in meat production can be attributed to consumer choices for wholesome, ethically procured food products, as well as apprehensions about animal welfare and environmental sustainability. Tylosin, a widespread antibiotic in livestock used to alleviate bacterial infections such as respiratory diseases and gastrointestinal issues, is also employed as a growth promoter in certain areas. For instance, the Department for Environmental Food and Rural Affairs, a UK governmental department, indicated in February 2024 that the total meat production in the US reached 4.2 million tons in 2022, portraying an increase of 18% compared to ten years ago. Additionally, there was a striking surge in red meat production, experiencing the most substantial growth in mutton and lamb at 2.9%. Moreover, home-fed production noticed a slight rise from 4,178 to 4,182 between 2020 and 2022. Hence, the escalating demand for healthy livestock is encouraging the growth of the tylosin market.
What key areas define the segmentation of the global tylosin Market?
The tylosin market covered in this report is segmented –
1) By Type: Tylosin Tartrate, Tylosin Phosphate, Other Types
2) By Application: Animal Feed Additives, Animal Drugs, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15946&type=smp
Who are the key firms paving the way for growth in the tylosin market?
Major companies operating in the tylosin market are Eli Lilly and Company, Zoetis Inc., Elanco Animal Health Inc., Ceva Santé Animale, Apeloa Pharmaceutical co. Ltd., Phibro Animal Health Corporation, Shandong Lukang Pharmaceutical Co. Ltd., Vetoquinol S.A., Norbrook Inc., Qilu Animal Health Products Co. Ltd., Merck & Co. Inc., Hebei Veyong Animal Pharmaceutical, Suanfarma SA, Huvepharma AD, Rochem International Inc., AdvaCare Pharma, Ningxia Tairui Pharmaceutical Co. Ltd., HangZhou Think Chemical Co. Ltd., Vetgen Healthcare Pvt Ltd., Anhui Sinotech Industrial, Pucheng Chia Tai Biochemistry Co Ltd., All Chem Bio Sciences, Nestlife Science Pvt Ltd., Sunvet Pharma Private Ltd., BOC Sciences
What key trends are currently impacting the tylosin market’s development?
Leading firms in the tylosin market are investing in groundbreaking solutions like tulathromycin injections to expand the range of treatment options for disease conditions in livestock. Tulathromycin injection serves as a comprehensive antibiotic in veterinary medicine, specifically for addressing respiratory and other ailments in livestock. In a case in point, Merck & Co. Inc., a pharmaceutical corporation based in the US, introduced Tulathromycin injection (Arovyn) in vials of 50, 100, 250, and 500 ml in May 2022. This drug is recommended for tackling bovine respiratory disease (BRD), foot rot, and pinkeye in cattle, as well as respiratory disease in pigs. Demonstrating effectiveness against pathogens including Mannheimia haemolytica, Pasteurella multocida, and Moraxella bovis, veterinarians and producers consider tulathromycin a cost-efficient treatment choice. However, it’s crucial to underline that female dairy cattle aged 20 months or above should not be given this drug, and an 18-day withdrawal period is mandated for cattle and a five-day period for swine before they’re slaughtered.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15946
Which regions are emerging as leaders in the tylosin market?
North America was the largest region in the tylosin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tylosin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Traumatic Brain Injuries Assessment Global Market Report 2024
Traumatic Brain Injuries Assessment Global Market Report 2024
Post-Traumatic Stress Disorder Therapeutics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
